Moreover, and importantly for our model choice, some HER2+ breast cancers have been shown to express both M-CSF1 and CSF1R fostering the crosstalk between this cancer subtype and TAMs (Riaz et al., 2021). This evidence concerns the gene ERBB2 and cancer.